EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
Recent Searches
Life Sciences
As costs escalate, demographics shift and regulatory complexities increase, life sciences companies can’t hold on to the past — new approaches are needed to deliver personalized care and better health outcomes faster and with greater efficiency.
34,500+
life sciences practitioners worldwide are ready to help clients today.
8,400+
global life sciences clients trust EY to help them demonstrate greater value.
US$1b+
annual investment in data, tech and AI to solve complex client challenges.
Solving your complex challenges
- Capital allocation
- Operational efficiency
- Digital manufacturing
- Launch optimization
CHALLENGE
Allocate capital effectively to generate growth, improve returns and achieve long-term objectives.
Companies need acquisitions and alliances to build their portfolios. With heavy competition for assets across a widening frontier of innovation, companies need to partner more effectively across a wider range of both technologies and geographies.
HOW EY CAN HELP
EY helps life sciences’ clients partner across the innovation ecosystem to accelerate growth, enhance agility, reduce time-to-market and scale impactful innovations.
- Value creation: Helping clients refine their growth strategy, perform deal sourcing, conduct diligence and valuation, and implement M&A integration.
- Deep insight into portfolio management: Facilitating strategic portfolio management and better divestments that help clients improve value from the sale of an entire company, carve-out, spin-off or joint venture.
- Financial performance transformation: Supporting clients with their business challenges from every angle and helping them rapidly create, preserve and recover value.
CHALLENGE
Improve operational efficiency by taking costs out to fund growth
Reducing costs and optimizing operations remains a top priority, across back-office functions from Global Business Services (GBS) to risk, regulatory and other processes. Agentic AI has emerged as a key lever for streamlining operations and protecting margins.
HOW EY CAN HELP
EY supports life sciences clients in achieving operational efficiency by helping them to optimize end-to-end value chain to control costs, ensure product/service quality and adherence to regulations, and fund innovation.
- Redesign operating models for agility: Helping clients rethink internal and external processes to drive speed, resilience and customer-centricity.
- Implement digital performance frameworks: Offering real-time data monitoring, cloud solutions and process integration to enhance manufacturing reliability and productivity. A digital-first approach supports cross-functional collaboration and long-term operational resiliency.
- Drive holistic transformation for sustainable success: Creating siloed operations and legacy systems with integrated strategies that align with evolving stakeholder expectations and regulatory demands.
- Enable talent for operational agility: Equipping teams with the right tools, training and upskilling programs to foster a culture of continuous improvement.
CHALLENGE
Configure adaptive manufacturing and supply chains
The industry’s manufacturing model faces onshoring pressures, soaring logistical costs, supply vulnerabilities and counterfeiting challenges. Companies need a smarter, AI-assisted digital manufacturing model that can ensure supply chain security, visibility, agility and operational resilience.
HOW EY CAN HELP
EY helps life sciences clients improve supply and demand synchronization via advanced analytics and the creation of new adaptive manufacturing capability.
- Smart manufacturing for resilient operations: Supporting clients in digitizing and automating core processes to improve quality, reducing costs and accelerating time-to-market.
- Predictive demand forecasting: Leveraging AI and advanced analytics to synchronize supply and demand, optimize inventory and improve production planning.
- AI-powered production transformation: Applying agentic AI, virtual twin technology and predictive analytics to optimize batch review, yield and quality control.
- Collaborative digital ecosystems: Building agile, cross-functional ecosystems that connect teams, data and systems across the value chain.
- Regulatory-ready automation: Deploying automation and digital tools that streamline compliance and reduce risk.
CHALLENGE
Use data more effectively to deliver innovation to patients faster
With development delays, failing launches and payer pushback, companies must bring commercial excellence into the end-to-end product lifecycle: accelerating from research and development to commercialization, leveraging next-generation Customer Relationship Management (CRM), and measuring real-world outcomes to support reimbursement.
HOW EY CAN HELP
EY helps life sciences implement new technologies and AI-powered solutions that enable holistic, high-quality care, products, services, and support digitized service models and operations.
- Accelerated launch strategies for market impact: Empowering biopharma teams to plan, execute and measure product launches with precision. Integrated strategy, operations and technology deliver faster, simpler and more successful launches.
- Behavioral benchmarking for salesforce excellence: Using data-led insights to optimize field-force performance, proven commercial behaviors are embedded in leaders and frontline teams to improve engagement and outcomes.
- Integrated CRM and regulatory platforms: Modernizing CRM and streamlining regulatory processes through unified platform adoption.
- Product Life Cycle and Portfolio management: Supporting clients in managing product portfolios and lifecycle strategies to improve commercial potential and align with evolving therapeutic priorities.
Explore our offerings
-
EY R&D Workbench for Pharma is a unique ERP solution that streamlines R&D, manufacturing, and compliance boosting speed, transparency, and efficiency.
Read more -
EY-Parthenon Health and Wellness Strategy Consulting teams help life sciences firms boost growth, resilience & agility through digital & value strategies.
Read more
EY-Parthenon: Transformative strategy and transactions – solutions that work in practice, not just on paper.
EY Partner Ecosystem
EY harnesses a connected ecosystem of strategic alliances and partnerships to co-create value and deliver comprehensive technology solutions and business outcomes for our clients.
Our latest thinking
What India’s OTC boom means for pharma companies
Listen to our latest podcast on India’s over the counter (OTC) pharmaceutical market as it evolves due to rising self care awareness, expanding digital commerce and gaps in healthcare accessibility.
9m 37s
How OTC is reshaping India’s pharmaceutical market
Learn how over-the-counter (OTC) dynamics are transforming India’s pharmaceutical market through shifting consumer behavior, regulatory clarity and insights into digital commerce.
Towards scalable, efficient and accountable healthcare in India
Discover insights from the FICCI-HEAL report on building scalable, efficient and accountable healthcare in India through quality, trust and innovation.
How innovation is shaping India’s key sectors
Explore how innovation in India leads growth across agriculture, energy, healthcare via agritech, clean energy, telemedicine, AI and sustainable tech.
How GCCs in India are shaping the future of the Life Sciences industry
Explore how India’s GCCs are transforming future of life sciences from handling core and enabling functions to driving innovation, outcome-oriented growth.
How to expand future-ready healthcare in India
Read how India’s healthcare is going digital with AI, telemedicine, data analytics, value-based care and interoperable platforms for better access & outcomes
How Agentic AI can transform industries by 2028
Agentic AI: Transforming industries by 2028 with autonomous decision-making, improved efficiency, and ethical frameworks. Learn how it’s reshaping businesses.
Why India should focus on health and education to achieve Viksit Bharat status
Prioritizing health and education is key to harnessing India's demographic dividend. Enhanced spending on these sectors fosters growth, employment, and productivity. Learn more.
Can AI drive scalable innovation in life sciences?
AI in life sciences is transforming healthcare with advancements in R&D, personalized medicine, MedTech innovation & strategies for sustainable AI adoption.
How much productivity can GenAI unlock in India? The AIdea of India 2025
Explore AIdea of India 2025 to find out how Gen AI is transforming industries, boosting productivity & reshaping India’s digital economy with innovation.
AIdea 2025 report - Industries in transformation: Life Sciences
GenAI is reshaping India’s life sciences sector, with 32%–34% productivity gains by 2030. Explore its role in drug discovery, manufacturing, & challenges.
What will it take for India to become a global pharma powerhouse by 2047?
Explore India’s roadmap to a $450B pharma industry by 2047, powered by digital transformation, AI-driven innovation, and strategic industry collaboration.
India’s MedTech transformation: paving the path to global leadership
India's MedTech industry is undergoing a revolution. Explore the latest trends, government support, and the potential for global dominance. Learn more.
Confronting India’s cancer crisis: The urgent need for affordable care
India battles rising cancer rates. Learn about challenges, prevention, early detection, and affordable treatment options. Know more.
Transforming healthcare in India with Generative AI
Explore how GenAI can revolutionize Indian healthcare by enhancing accessibility, quality & collaboration while integrating tech with thoughtful oversight.
Driving Competitive Differentiation: M&A Outlook for 2023 in Tech Services
Explore Indias healthcare evolution and future goals in our in-depth analysis. Uncover the strides and vision for a healthier India. Learn more.
How sustainable practices ensure a green healthcare ecosystem
EY explores how climate change is transforming healthcare system globally, leading to eco-friendly hospitals & sustainable, patient-centric infrastructure.
Meet our Life Sciences consulting team
Suresh Subramanian
National Life Sciences Leader, EY Parthenon India
Sumeet Chandna
Partner – Life Sciences, EY Parthenon India
Explore related sector pages: Consumer Products | Health | Retail